Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · IEX Real-Time Price · USD
0.525
-0.006 (-1.15%)
Jul 22, 2024, 9:30 AM EDT - Market open
Evoke Pharma Employees
Evoke Pharma had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,526,428
Profits / Employee
-$1,782,261
Market Cap
4.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Genetic Technologies | 60 |
Intelligent Bio Solutions | 51 |
Predictive Oncology | 35 |
Theriva Biologics | 22 |
Processa Pharmaceuticals | 13 |
Sonnet BioTherapeutics Holdings | 12 |
Adial Pharmaceuticals | 7 |
Portage Biotech | 7 |
EVOK News
- 5 weeks ago - Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI - GlobeNewsWire
- 2 months ago - Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference - GlobeNewsWire
- 2 months ago - Evoke Pharma Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications - GlobeNewsWire
- 4 months ago - Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer - GlobeNewsWire
- 4 months ago - Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024 - GlobeNewsWire
- 5 months ago - Evoke Pharma Announces Closing of $7.5 Million Public Offering - GlobeNewsWire